Kinase Inhibitors and Ovarian Cancer

Ovarian cancer is fifth in the rankings of cancer deaths among women, and accounts for more deaths than any other gynecological malignancy. Despite some improvement in overall-(OS) and progression-free survival (PFS) following surgery and first-line chemotherapy, there is a need for development of n...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Katopodis, Periklis, Chudasama, Dimple, Wander, Gurleen, Sales, Louise, Kumar, Juhi, Pandhal, Manreen, Anikin, Vladimir, Chatterjee, Jayanta, Hall, Marcia, Karteris, Emmanouil
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770231/
https://ncbi.nlm.nih.gov/pubmed/31547471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091357
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items